1. Introduction: The "Clinical Evaluation Report" as a Key to Bridging the Device Lag
In medical device development, the biggest hurdle is "clinical trials." While clinical trials are costly and time-consuming, the Japanese regulatory system actually offers a path to obtain approval without conducting new clinical trials by submitting a "Clinical Evaluation Report" that utilizes existing literature and data.
This article will explain specific strategies for cases where a Clinical Evaluation Report is likely to be accepted.
2. "Three Main Categories" for Approval Without Clinical Trials
Whether PMDA (Pharmaceuticals and Medical Devices Agency) accepts a Clinical Evaluation Report is primarily based on the following three concepts:
| Category | Evaluation Axis | Specific Cases |
|---|---|---|
| Category A | Medically and pharmacologically well-known | Cases where high-level evidence papers (e.g., meta-analyses of RCTs) exist for the product itself, and it is recommended by international guidelines. |
| Category B | Clinical effect due to physical performance is well-known | Cases where the effect due to physical performance, such as "making a hole" or "closing a hole," is already established by existing similar devices or procedures, and equivalence can be explained by non-clinical tests. |
| Category C | Almost fully explainable by non-clinical tests (Only human confirmation required) | Cases where efficacy and safety have been largely evaluated by animal studies, etc., but overseas clinical research data are utilized as supporting evidence to confirm extrapolation to humans. |
3. "Three-Stage Process" for Creating a Successful Report
The creation of the report must proceed logically through the following steps:
Stage 1: Identification and Collection of Clinical Data
Conduct a "comprehensive" and non-arbitrary literature search, identifying the scope to include not only the device in question but also similar devices and previous models.
Stage 2: Evaluation and Selection of Data
Weight the collected literature based on its "level of evidence." It is necessary to state not only the good data but also the excluded literature and the reasons for exclusion.
Stage 3: Data Analysis
Make an overall judgment on whether the device "operates as intended," "is effective and safe," and whether "the risks are acceptable compared to the benefits."
4. Shortcut to Approval: Utilizing PMDA Consultation
The acceptance of a Clinical Evaluation Report is ultimately determined by a comprehensive judgment for each individual product. To resolve questions such as "Is this paper sufficient?" or "How should the differences from similar devices be explained?", it is recommended to utilize PMDA consultation from the early stages of development to proceed with a shared understanding.
5. Conclusion
The "Clinical Evaluation Report" is a rational scheme for delivering the latest medical devices to medical settings more quickly. By carefully examining which category your product falls into and accumulating evidence, aim for efficient approval.
Need help with Japan's medical device approval?
Our regulatory affairs consultants specializing in digestive endoscopy devices provide end-to-end support from strategy to document preparation. Contact us for a free initial consultation.
Free Consultation